ClinicalTrials.gov
public full text
Public Domain
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)#884876
- Antibiotic Prescriptions for Non-severe Urinary Tract Infections: A Single-Center Retrospective Study to Guide Antibiotic Stewardship#1079561
- Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care#893654
- Knowledge Towards Antibiotics Use Among Lebanese Adults#242006
- A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections#803812
Record · ID 903466
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive